32
Participants
Start Date
January 31, 2006
Primary Completion Date
February 29, 2008
Study Completion Date
November 30, 2010
Vinflunine
Novel second generation vinca alkaloid
Trastuzumab
Anti-HER2 monoclonal antibody
Spartanburg Regional Medical Center, Spartanburg
Northeast Georgia Medical Center, Gainesville
Integrated Community Oncology Network, Jacksonville
Watson Clinic Center for Cancer Care and Research, Lakeland
Florida Cancer Specialists, Fort Myers
Northeast Alabama Regional Medical Center, Anniston
Tennessee Oncology, Nashville
Associates in Hematology Oncology, Chattanooga
Grand Rapids Clinical Oncology Program, Grand Rapids
Hematology Oncology Life Center, Alexandria
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
SCRI Development Innovations, LLC
OTHER